These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35464428)

  • 1. TNFAIP3 Reduction-of-Function Drives Female Infertility and CNS Inflammation.
    Zammit NW; McDowell J; Warren J; Muskovic W; Gamble J; Shi YC; Kaczorowski D; Chan CL; Powell J; Ormandy C; Brown D; Oakes SR; Grey ST
    Front Immunol; 2022; 13():811525. PubMed ID: 35464428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of the cytoplasmic ubiquitin ligase TNFAIP3 gene variation on transcription factor NF-κB activation in acute kidney injury.
    Rogers NM; Zammit N; Nguyen-Ngo D; Souilmi Y; Minhas N; Meijles DN; Self E; Walters SN; Warren J; Cultrone D; El-Rashid M; Li J; Chtanova T; O'Connell PJ; Grey ST
    Kidney Int; 2023 Jun; 103(6):1105-1119. PubMed ID: 37097268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-α-induced protein 3 (TNFAIP3)/A20 acts as a master switch in TNF-α blockade-driven IL-17A expression.
    Urbano PCM; Aguirre-Gamboa R; Ashikov A; van Heeswijk B; Krippner-Heidenreich A; Tijssen H; Li Y; Azevedo VF; Smits LJT; Hoentjen F; Joosten I; Koenen HJPM
    J Allergy Clin Immunol; 2018 Aug; 142(2):517-529. PubMed ID: 29248493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Denisovan, modern human and mouse TNFAIP3 alleles tune A20 phosphorylation and immunity.
    Zammit NW; Siggs OM; Gray PE; Horikawa K; Langley DB; Walters SN; Daley SR; Loetsch C; Warren J; Yap JY; Cultrone D; Russell A; Malle EK; Villanueva JE; Cowley MJ; Gayevskiy V; Dinger ME; Brink R; Zahra D; Chaudhri G; Karupiah G; Whittle B; Roots C; Bertram E; Yamada M; Jeelall Y; Enders A; Clifton BE; Mabbitt PD; Jackson CJ; Watson SR; Jenne CN; Lanier LL; Wiltshire T; Spitzer MH; Nolan GP; Schmitz F; Aderem A; Porebski BT; Buckle AM; Abbott DW; Ziegler JB; Craig ME; Benitez-Aguirre P; Teo J; Tangye SG; King C; Wong M; Cox MP; Phung W; Tang J; Sandoval W; Wertz IE; Christ D; Goodnow CC; Grey ST
    Nat Immunol; 2019 Oct; 20(10):1299-1310. PubMed ID: 31534238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNGR1-mediated deletion of A20/Tnfaip3 in dendritic cells alters T and B-cell homeostasis and promotes autoimmune liver pathology.
    Das T; Bergen IM; Koudstaal T; van Hulst JAC; van Loo G; Boonstra A; Vanwolleghem T; Leung PSC; Gershwin ME; Hendriks RW; Kool M
    J Autoimmun; 2019 Aug; 102():167-178. PubMed ID: 31151831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models.
    Das T; Chen Z; Hendriks RW; Kool M
    Front Immunol; 2018; 9():104. PubMed ID: 29515565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel missense mutation in TNFAIP3 causes haploinsufficiency of A20.
    Jiang W; Deng M; Gan C; Wang L; Mao H; Li Q
    Cell Immunol; 2022 Jan; 371():104453. PubMed ID: 34808442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single nucleotide polymorphisms at the TNFAIP3/A20 locus and susceptibility/resistance to inflammatory and autoimmune diseases.
    Mele A; Cervantes JR; Chien V; Friedman D; Ferran C
    Adv Exp Med Biol; 2014; 809():163-83. PubMed ID: 25302371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An enhancer element harboring variants associated with systemic lupus erythematosus engages the TNFAIP3 promoter to influence A20 expression.
    Wang S; Wen F; Wiley GB; Kinter MT; Gaffney PM
    PLoS Genet; 2013; 9(9):e1003750. PubMed ID: 24039598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell deficiency influences megakaryocytopoiesis through the TNFAIP3/NF-κB/SMAD pathway in patients with immune thrombocytopenia.
    He Y; Xu LL; Feng FE; Wang QM; Zhu XL; Wang CC; Zhang JM; Fu HX; Xu LP; Liu KY; Huang XJ; Zhang XH
    Br J Haematol; 2018 Feb; 180(3):395-411. PubMed ID: 29327472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic activation of NF-κB by TNFAIP3 (A20) reduction and UBE2L3 (UBCH7) augment that synergistically elevate lupus risk.
    Kim T; Bae SC; Kang C
    Arthritis Res Ther; 2020 Apr; 22(1):93. PubMed ID: 32334614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional variants of TNFAIP3 are associated with systemic lupus erythematosus in a cohort of Chinese Han population.
    Xu M; Gao W; Wu L; Liu X; Yu D; Shi X; Liu X; Wang Q; Fu X; Yu J; Xu B; Wang S
    Hum Immunol; 2019 Feb; 80(2):140-145. PubMed ID: 30529365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Autoimmune Disease-Associated Risk Variant in the
    Lou L; Bao W; Liu X; Song H; Wang Y; Zhang K; Gao W; Li H; Tu Z; Wang S
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29343543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Context-dependent cooperation between nuclear factor κB (NF-κB) and the glucocorticoid receptor at a TNFAIP3 intronic enhancer: a mechanism to maintain negative feedback control of inflammation.
    Altonsy MO; Sasse SK; Phang TL; Gerber AN
    J Biol Chem; 2014 Mar; 289(12):8231-9. PubMed ID: 24500711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A zebrafish functional genomics model to investigate the role of human A20 variants in vivo.
    Cultrone D; Zammit NW; Self E; Postert B; Han JZR; Bailey J; Warren J; Croucher DR; Kikuchi K; Bogdanovic O; Chtanova T; Hesselson D; Grey ST
    Sci Rep; 2020 Nov; 10(1):19085. PubMed ID: 33154446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-125b promotes the NF-κB-mediated inflammatory response in NAFLD via directly targeting TNFAIP3.
    Zhang Q; Yu K; Cao Y; Luo Y; Liu Y; Zhao C
    Life Sci; 2021 Apr; 270():119071. PubMed ID: 33515562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the NF-κB Pathway and Heterozygous Deletion of TNFAIP3 (A20) Confer Superior Survival in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.
    Liu F; Zheng JP; Wang L; Zhao DH; Li MY; Wang YM; Liu Y; Ma J; Zeng NY; Liu HX; Liang R; Guo SP; Wang Z; Yan QG
    Am J Clin Pathol; 2019 Jul; 152(2):243-252. PubMed ID: 31140551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of novel A20 variants in patients with atypical inflammatory diseases.
    Kadowaki S; Hashimoto K; Nishimura T; Kashimada K; Kadowaki T; Kawamoto N; Imai K; Okada S; Kanegane H; Ohnishi H
    Arthritis Res Ther; 2021 Feb; 23(1):52. PubMed ID: 33549127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A De Novo Frameshift Mutation in TNFAIP3 Impairs A20 Deubiquitination Function to Cause Neuropsychiatric Systemic Lupus Erythematosus.
    Duan R; Liu Q; Li J; Bian X; Yuan Q; Li Y; Long F; Gao S; Wei S; Li P; Gao F; Sun W; Li X; Liu Q
    J Clin Immunol; 2019 Nov; 39(8):795-804. PubMed ID: 31625129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haploinsufficiency of A20 Due to Novel Mutations in TNFAIP3.
    He T; Huang Y; Luo Y; Xia Y; Wang L; Zhang H; Ling J; Yang J
    J Clin Immunol; 2020 Jul; 40(5):741-751. PubMed ID: 32514655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.